Triastek's 3D Printed Gastric Retention Product T22 Receives FDA Clearance of IND Application
- Written by The Bulletin
- Triastek's 3D printed gastric retention product T22 received IND clearance from the FDA, becoming the world's first 3D printed gastric retention product.
- Currently, Triastek has four 3D printed products, T19, T20, T21, and T22, that have obtained IND clearance from the FDA, ranking Triastek first in the global 3D printed field for pharmaceutical clinical development.
